Pure Global

"Haifeng Biomedicine" Dabigatran correction solution - Taiwan Registration 7a3bde0a72fa6c811ace2fbdc08fc916

Access comprehensive regulatory information for "Haifeng Biomedicine" Dabigatran correction solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7a3bde0a72fa6c811ace2fbdc08fc916 and manufactured by HYPHEN BioMed. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
7a3bde0a72fa6c811ace2fbdc08fc916
Registration Details
Taiwan FDA Registration: 7a3bde0a72fa6c811ace2fbdc08fc916
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Haifeng Biomedicine" Dabigatran correction solution
TW: โ€œๆตทๅฅ‰็”Ÿ็‰ฉ้†ซๅญธโ€ Dabigatran ๆ กๆญฃๆถฒ
Risk Class 2

Registration Details

7a3bde0a72fa6c811ace2fbdc08fc916

DHA05603415507

Company Information

France

Product Details

This product is lyophilized human plasma doped with different concentrations of Dabigatran for correction of Dabigatran measurements.

A Clinical chemistry and clinical toxicology

A.1150 Calibrated Products

QMS/QSD;; ่ผธๅ…ฅ

Dates and Status

Nov 09, 2020

Nov 09, 2025